Akari Therapeutics (AKTX) Shareholder's Equity Growth (5y) (2016 - 2025)
Akari Therapeutics (AKTX) Shareholder's Equity Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.73% |
| Sep 30, 2025 | 26.70% |
| Jun 30, 2025 | 33.86% |
| Mar 31, 2025 | 46.08% |
| Dec 31, 2024 | 393.45% |
| Sep 30, 2024 | -27.47% |
| Jun 30, 2024 | -58.68% |
| Mar 31, 2024 | -22.28% |
| Dec 31, 2023 | -15.47% |
| Dec 31, 2022 | -39.58% |
| Dec 31, 2021 | -30.44% |
| Dec 31, 2020 | -28.07% |
| Sep 30, 2020 | -30.00% |
| Jun 30, 2020 | 43.68% |
| Mar 31, 2020 | 4.72% |
| Dec 31, 2019 | -67.88% |
| Jun 30, 2019 | -46.43% |
| Dec 31, 2018 | 61.25% |
| Dec 31, 2017 | 53.84% |
| Dec 31, 2016 | 73.50% |